See analyst estimates and all valuation multiples for Nutraceuticals & Cosmeceuticals
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $29.7B | 1.9x | 7.9x | |
| $18.6B | 16.3x | 50.1x | |
| $14.5B | 9.9x | 30.4x | |
| $10.3B | 3.1x | 7.4x | |
| $7.2B | 4.6x | 23.0x | |
| $6.4B | 8.4x | 31.0x | |
| $3.4B | 1.6x | 9.7x | |
| $3.4B | 2.4x | 8.9x | |
| $2.9B | 1.4x | 9.4x | |
| $2.4B | 6.6x | 15.2x | |
| $2.0B | 1.9x | 7.6x | |
| $1.6B | n/a | n/a | |
| $1.4B | 4.8x | 9.4x | |
| $1.3B | 2.1x | 11.0x | |
| $1.1B | 4.9x | 17.9x | |
| $1.0B | 7.9x | 29.6x | |
| $981M | n/a | n/a | |
| $977M | 6.2x | 21.7x | |
| $891M | 3.7x | 9.0x | |
| $823M | 1.8x | 8.8x | |
| $814M | n/a | n/a | |
| $597M | 3.9x | 15.4x | |
| $593M | 13.8x | 39.5x | |
| $507M | n/a | n/a | |
| $468M | 3.7x | 23.8x | |
| $322M | n/a | n/a | |
| $291M | n/a | n/a | |
| $211M | 2.6x | 15.0x | |
| $188M | 2.9x | n/a | |
| $133M | 2.0x | 12.2x | |
| $72.5M | n/a | n/a | |
| $71.2M | n/a | n/a | |
| $58.6M | 4.0x | 43.1x | |
| $44.7M | 1.3x | 4.4x | |
| $29.0M | n/a | n/a | |
| $20.0M | n/a | n/a | |
| $13.8M | 0.7x | -8.2x | |
| $10.2M | 8.5x | -1.0x | |
| $6.8M | n/a | n/a | |
| $6.2M | n/a | n/a | |
| $3.5M | n/a | n/a | |
| -$1.2M | n/a | n/a | |
| -$61.0M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Nutraceuticals & Cosmeceuticals